The second wave of coronavirus all over the world is hunting people more frighteningly. Not only are the cases increasing day by day, but the death toll is also increasing rapidly. This has made the race for the vaccine even faster. After China and Russia, now the UAE has also approved the vaccine. This vaccine is made by the Chinese company Sinopharm. Phase-3 trials of this vaccine are still ongoing. Meanwhile, both indigenous vaccines of India have completed Phase-I trials. Volunteers for Phase-2 have also been recruited. The Serum Institute has been granted permission to reintroduce trials of Kovishield, a Covid-19 vaccine from Oxford / AstraZeneca.
Coveshield: Trials resumed in England, India, stopped in the US
After England, India has also permitted to resume the trial trials of the Oxford / AstraZeneca vaccine. The Serum Institute of India (SSI) in India has started Phase-2 and Phase-3 trials of this vaccine. At the same time, the Drug Regulator Food and Drug Administration in the US has not taken a decision yet. At the same time, the National Institute of Health has started investigating the reasons for stopping the trials.
A woman's health worsened during the Phase-2 and Phase-3 trials of Coveshield, the Oxford / AstraZeneca vaccine in England. After this, his trials were banned all over the world including India. The Independent Expert Committee and the UK's Drug Regulator have permitted for the trials to be resumed after investigation. The woman, who was ill, has also been discharged from the hospital.
Phase-1 trials of both indigenous vaccines were successful.
Director-General of ICMR, Dr. Balaram Bhargava said that both indigenous vaccine candidates (Kovaxin of Bharat Biotech and Candidate of Zydus Cadila) have completed Phase-1 trials. So far both have been safe and effective.
Dr. Bhargava said that Zydus Cadila has completed recruitment for Phase-2. Three doses will be given at a difference of 28 days. Similarly, phase-2 recruitment has also been done for Bharat Biotech's Kovaxin. Volunteers will be given two doses in this phase.
Dr. Bhargava says that the Serum Institute of India has completed Phase-2 trials. Vaccine doses have been given to 100 volunteers for this. After a seven-day gap, Phase-3 trials will start at 1,500 volunteers at 14 sites.
Discussions are being held between the Russian government, diplomats, and high-level Indian expert committee on the issue of phase-3 trials of the Russian vaccine in India. Dr. Bhargava said that not much can be said in this regard at the moment. Russia has also started phase-3 trials of the vaccine.
Novavax will now make 2 billion vaccine doses in India
In August, the US company Novavax signed a deal with the world's largest vaccine producer Serum Institute of India to manufacture at least one billion vaccine doses. Now he has doubled this deal to two billion vaccine doses.
Under the new agreement, Serum Institute will also manufacture vaccine antigen component NVX ‑ CoV2373. This will enable the production of two billion doses by June 2021. Novavax vaccine has been safe and effective in the initial stage. The company is scheduled to start Phase-3 trials in October.
Trump claims - vaccine will be available in a month
US President Donald Trump has claimed that the coronavirus vaccine may be available within a month. It also said that this epidemic will end by itself.
During a Q&A session with voters in Pennsylvania, Trump said, "We are very close to getting the vaccine." We will have the vaccine in a few weeks. It may take four weeks and 8 weeks.
Democrats have voiced concern over Trump's statements. He says Trump is pressurizing the government health regulator by making such promises that he approves the coronavirus vaccine as soon as possible. This makes him want to strengthen his turn against Joe Biden, a Democrat candidate in elections.
Scientists not satisfied with Russian vaccine data, sought and data
The results of the initial trials of the Russian vaccine SPUTNIK V, despite appearing in the medical journal Lancet, have not convinced his safety. A group of international scientists have questioned the data published in the study. They have drawn attention to potential flaws.
40 scientists have demanded original data by writing an open letter to Gamalaya Institute, the developer of the Russian vaccine. The study published in the Lancet does not contain complete data. The developers have claimed that their vaccine has been completely safe and effective in Phase-1 and Phase-2.
UAE approves Chinese vaccine
The UAE has become the third country in the world to approve the use of the coronavirus vaccine. It has approved the vaccine of Chinese state-run Sinoform. The company had been doing vaccine trials in the UAE for the past six months.
Phase-3 trials of Sinopharm are not over yet. The UAE government said that this vaccine would first be given to defense heroes who are at the highest risk of infection with the virus.
This Covid-19 vaccine from Sinopharm was approved by China on July 22, even before the phase-3 trials began. China has also approved two other vaccines, but their Phase-3 trials have not yet been completed. Similarly, Russia has already approved SPUTNIK V before the results of Phase-3 trials.
Now Pfizer will conduct vaccine trials on 44,000 people
Pfizer, which is among the leading companies in the race for the Covid-19 vaccine, said its vaccine is safe and the company hopes to get the data next month. Pfizer CEO Albert Baurla said that to make the process open and transparent, they are sharing information as quickly as possible.
The company has said that now it has increased the scope of trials from 30 thousand to 44 thousand people. The 16 to 18-year-old teenager will also be included in this. Besides, patients suffering from HIV, Hepatitis A, B, or C will also be enrolled.
WHO Says Vaccine Landscape…
180 vaccines are currently being developed all over the world.
35 vaccines are undergoing clinical trials.
9 vaccines are in Phase-3 ie final round trials. There are also four vaccines being developed in China.
145 vaccines are in the phase of pre-clinical trials. That is, their evaluation is still going on in the labs.
IGNOU Registration 2023: Apply for admission in January session in IGNOU from today, this is the process
Indira Gandhi National Open University (IGNOU) has started admission for January 2023 session. Applicants seeking admission can apply for several courses offered by the university at the official
Girlfriend came to India by swimming from Bangladesh: 22-year-old girl swam in the river for an hour, married her lover; now arrested
The love that does not make is less. This is what you would say after hearing the story of 22-year-old Krishna Mandal who came to India from Bangladesh. She came to West Bengal after crossing the
Madarsa Education: Now scholarships will not be available in madrasas till eighth grade, Central Government issued an order
The scholarship will not be given to students studying in classes one to eight in the madrassas of Uttar Pradesh from the academic session 2022-23. Instructions have been issued in this regard by the
UEFA Champions League: Karim Benzema dashes hopes of Liverpool's return by scoring a goal
Following a 7–0 win against Manchester United in the English Premier League, Liverpool fans were also pinning hopes on the team's historic return to the Champions League. However, Liverpool were
Pushpa 2 Song Kissik Out: 'Pushpa 2' new song 'Kisik' released, Allu Arjun and Srileela's pairing rocked
One of the biggest films of the year, 'Pushpa 2: The Rule' is going to hit the theatres soon. There is a lot of buzz about this film even before its release. At the same time, increasing the
Testing at the airport, 15 labs ready; Government told the plan to deal with monkeypox
Monkeypox has also knocked in the country amid the threat of Corona. So far, 4 cases of monkeypox have been confirmed in India. On Tuesday, NITI Aayog member Dr. VK Paul said that the government has
Joe Root claimed, that Ben Stokes has a plan for the test match against India too
England captain Ben Stokes has given credit for picking the best player and new coach Brendon McCullum for the 3-0 Test series against New Zealand. Before this series, the England team had been losing
'Direct Chief Minister' program started to listen to public complaints, CM Mamta will listen to people's complaints
Bengal Chief Minister Mamata Banerjee started a new program called 'Side Chief Minister' on Thursday just before the Panchayat elections on the lines of Didi Ke Bolo to listen to the grievances of the
Why India can outdo Pakistan in Asia Cup 2022, explains Rashid Latif
The last match between Team India and Pakistan was played on 24 October 2021 and now after about 10 months, once again both the teams will face each other once again on the same ground. On August 28,
Center's response to Maharashtra, 5 lakh doses of waste, the work of the state government in the distribution of districts
A round of accusations has begun between the Center and the Maharashtra government over the Corona vaccine. Responding to Maharashtra's charge of under-supply of the vaccine, the Center has accused
